53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers

被引:0
|
作者
Peter Bouwman
Amal Aly
Jose M Escandell
Mark Pieterse
Jirina Bartkova
Hanneke van der Gulden
Sanne Hiddingh
Maria Thanasoula
Atul Kulkarni
Qifeng Yang
Bruce G Haffty
Johanna Tommiska
Carl Blomqvist
Ronny Drapkin
David J Adams
Heli Nevanlinna
Jiri Bartek
Madalena Tarsounas
Shridar Ganesan
Jos Jonkers
机构
[1] The Netherlands Cancer Institute,Division of Molecular Biology
[2] Cancer Institute of New Jersey,Department of Obstetrics and Gynecology
[3] Telomere and Genome Stability Group,Department of Oncology
[4] The Cancer Research UK-MRC Gray Institute for Radiation Oncology and Biology,Department of Medical Oncology
[5] Institute of Cancer Biology and Centre for Genotoxic Stress Research,undefined
[6] Danish Cancer Society,undefined
[7] Helsinki University Central Hospital,undefined
[8] Helsinki University Central Hospital,undefined
[9] Center of Molecular Oncologic Pathology,undefined
[10] Dana-Farber Cancer Institute,undefined
[11] Wellcome Trust Sanger Institute,undefined
[12] Wellcome Trust Genome Campus Hinxton,undefined
[13] Institute of Molecular and Translational Medicine,undefined
[14] Palacky University,undefined
来源
Nature Structural & Molecular Biology | 2010年 / 17卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A transposon mutagenesis screen indicates that loss of 53BP1 expression rescues the clonal growth defect of BRCA1 null cells. 53BP1 deficiency is shown to abrogate the cell cycle arrest triggered in the absence of BRCA1 and to partially restore homologous recombination. The potential clinical implications of these findings are supported by the reduction of 53BP1 expression in sporadic triple-negative and BRCA-associated breast cancers.
引用
收藏
页码:688 / 695
页数:7
相关论文
共 50 条
  • [1] 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
    Bouwman, Peter
    Aly, Amal
    Escandell, Jose M.
    Pieterse, Mark
    Bartkova, Jirina
    van der Gulden, Hanneke
    Hiddingh, Sanne
    Thanasoula, Maria
    Kulkarni, Atul
    Yang, Qifeng
    Haffty, Bruce G.
    Tommiska, Johanna
    Blomqvist, Carl
    Drapkin, Ronny
    Adams, David J.
    Nevanlinna, Heli
    Bartek, Jiri
    Tarsounas, Madalena
    Ganesan, Shridar
    Jonkers, Jos
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2010, 17 (06) : 688 - U56
  • [2] Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
    Glodzik, Dominik
    Bosch, Ana
    Hartman, Johan
    Aine, Mattias
    Vallon-Christersson, Johan
    Reutersward, Christel
    Karlsson, Anna
    Mitra, Shamik
    Nimeus, Emma
    Holm, Karolina
    Hakkinen, Jari
    Hegardt, Cecilia
    Saal, Lao H.
    Larsson, Christer
    Malmberg, Martin
    Ryden, Lisa
    Ehinger, Anna
    Loman, Niklas
    Kvist, Anders
    Ehrencrona, Hans
    Nik-Zainal, Serena
    Borg, Ake
    Staaf, Johan
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [3] Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
    Dominik Glodzik
    Ana Bosch
    Johan Hartman
    Mattias Aine
    Johan Vallon-Christersson
    Christel Reuterswärd
    Anna Karlsson
    Shamik Mitra
    Emma Niméus
    Karolina Holm
    Jari Häkkinen
    Cecilia Hegardt
    Lao H. Saal
    Christer Larsson
    Martin Malmberg
    Lisa Rydén
    Anna Ehinger
    Niklas Loman
    Anders Kvist
    Hans Ehrencrona
    Serena Nik-Zainal
    Åke Borg
    Johan Staaf
    Nature Communications, 11
  • [4] Loss of 53BP1 Is a Gain for BRCA1 Mutant Cells
    Kass, Elizabeth M.
    Moynahan, Mary Ellen
    Jasin, Maria
    CANCER CELL, 2010, 17 (05) : 423 - 425
  • [5] Loss of BRCA1 expression and morphological features associated with BRCA1 promoter methylation status in triple-negative breast cancer
    Morizono, Arisa
    Tanabe, Masahiko
    Ikemura, Masako
    Sasaki, Takeshi
    Ushiku, Tetsuo
    Seto, Yasuyuki
    JOURNAL OF HUMAN GENETICS, 2021, 66 (08) : 785 - 793
  • [6] Loss of BRCA1 expression and morphological features associated with BRCA1 promoter methylation status in triple-negative breast cancer
    Arisa Morizono
    Masahiko Tanabe
    Masako Ikemura
    Takeshi Sasaki
    Tetsuo Ushiku
    Yasuyuki Seto
    Journal of Human Genetics, 2021, 66 : 785 - 793
  • [7] 53BP1 loss rescues embryonic lethality but not genomic instability of BRCA1 total knockout mice
    Jiyuan Chen
    Peng Li
    Licun Song
    Long Bai
    Michael S. Y. Huen
    Yidan Liu
    Lin-Yu Lu
    Cell Death & Differentiation, 2020, 27 : 2552 - 2567
  • [8] 53BP1 loss rescues embryonic lethality but not genomic instability of BRCA1 total knockout mice
    Chen, Jiyuan
    Li, Peng
    Song, Licun
    Bai, Long
    Huen, Michael S. Y.
    Liu, Yidan
    Lu, Lin-Yu
    CELL DEATH AND DIFFERENTIATION, 2020, 27 (09): : 2552 - 2567
  • [9] BRCA1 methylation in triple-negative breast cancer
    Kawachi, A.
    Okochi-Takada, E.
    Shimoi, T.
    Shimomura, A.
    Kodaira, M.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Ushijima, T.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2015, 26 : 28 - 29
  • [10] BRCA1 testing for triple-negative breast cancer
    Bennet, Neil
    LANCET ONCOLOGY, 2012, 13 (04): : E143 - E143